Free Trial

Kayne Anderson Rudnick Investment Management LLC Sells 47,230 Shares of HealthEquity, Inc. $HQY

HealthEquity logo with Medical background

Key Points

  • Kayne Anderson Rudnick Investment Management LLC reduced its holdings in HealthEquity by 6.1%, now owning approximately 0.84% of the company, valued at $64.1 million.
  • Several institutional investors, including Comerica Bank and Northwestern Mutual Wealth Management Co., have increased their positions in HealthEquity, with institutional ownership now at 99.55%.
  • HealthEquity reported a $0.97 EPS for the last quarter, exceeding analyst expectations, and it has set a fiscal year 2026 guidance of 3.610-3.78 EPS.
  • Want stock alerts on HealthEquity? Get 5 Weeks of MarketBeat All Access for $5. Get My Stock Alerts.

Kayne Anderson Rudnick Investment Management LLC reduced its stake in HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 6.1% during the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 725,551 shares of the company's stock after selling 47,230 shares during the period. Kayne Anderson Rudnick Investment Management LLC owned 0.84% of HealthEquity worth $64,117,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Versant Capital Management Inc bought a new position in HealthEquity during the first quarter worth about $28,000. Northwestern Mutual Wealth Management Co. raised its position in shares of HealthEquity by 176.4% in the 1st quarter. Northwestern Mutual Wealth Management Co. now owns 655 shares of the company's stock valued at $58,000 after acquiring an additional 418 shares during the period. Larson Financial Group LLC raised its position in shares of HealthEquity by 1,366.0% in the 1st quarter. Larson Financial Group LLC now owns 689 shares of the company's stock valued at $61,000 after acquiring an additional 642 shares during the period. BI Asset Management Fondsmaeglerselskab A S bought a new position in HealthEquity during the 1st quarter worth approximately $65,000. Finally, Whipplewood Advisors LLC grew its holdings in HealthEquity by 5,060.0% during the first quarter. Whipplewood Advisors LLC now owns 774 shares of the company's stock valued at $68,000 after purchasing an additional 759 shares during the period. Institutional investors own 99.55% of the company's stock.

HealthEquity Stock Down 1.5%

HQY stock traded down $1.35 during trading hours on Wednesday, reaching $87.98. 872,967 shares of the stock were exchanged, compared to its average volume of 943,650. The firm's 50-day moving average is $96.01 and its 200-day moving average is $96.15. HealthEquity, Inc. has a 12 month low of $73.84 and a 12 month high of $116.65. The company has a market cap of $7.61 billion, a price-to-earnings ratio of 64.22, a PEG ratio of 1.38 and a beta of 0.54. The company has a debt-to-equity ratio of 0.50, a current ratio of 4.06 and a quick ratio of 4.06.

HealthEquity (NASDAQ:HQY - Get Free Report) last issued its quarterly earnings results on Tuesday, June 3rd. The company reported $0.97 EPS for the quarter, beating analysts' consensus estimates of $0.81 by $0.16. The company had revenue of $330.80 million for the quarter, compared to analyst estimates of $322.25 million. HealthEquity had a return on equity of 11.01% and a net margin of 9.80%.During the same period in the previous year, the company posted $0.80 earnings per share. HealthEquity has set its FY 2026 guidance at 3.610-3.78 EPS. On average, equities research analysts expect that HealthEquity, Inc. will post 2.32 earnings per share for the current year.

Insiders Place Their Bets

In other news, Director Jon Kessler sold 134,183 shares of the firm's stock in a transaction that occurred on Friday, June 6th. The shares were sold at an average price of $112.08, for a total transaction of $15,039,230.64. Following the completion of the transaction, the director directly owned 253,510 shares of the company's stock, valued at $28,413,400.80. This trade represents a 34.61% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Elimelech Rosner sold 58,000 shares of HealthEquity stock in a transaction that occurred on Friday, June 6th. The shares were sold at an average price of $112.56, for a total transaction of $6,528,480.00. Following the completion of the sale, the executive vice president owned 75,689 shares in the company, valued at $8,519,553.84. This trade represents a 43.38% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 291,744 shares of company stock valued at $32,705,007 in the last quarter. 1.50% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

Several equities research analysts have weighed in on HQY shares. Bank of America increased their target price on shares of HealthEquity from $110.00 to $125.00 and gave the stock a "buy" rating in a report on Wednesday, June 4th. Wall Street Zen upgraded shares of HealthEquity from a "hold" rating to a "buy" rating in a research report on Friday, June 6th. Barrington Research raised their price objective on HealthEquity from $112.00 to $125.00 and gave the stock an "outperform" rating in a research note on Thursday, June 5th. Raymond James Financial reiterated a "strong-buy" rating and set a $120.00 target price (up from $115.00) on shares of HealthEquity in a report on Tuesday, July 8th. Finally, Deutsche Bank Aktiengesellschaft increased their price target on HealthEquity from $98.00 to $115.00 and gave the stock a "buy" rating in a report on Thursday, June 5th. One equities research analyst has rated the stock with a Strong Buy rating, nine have given a Buy rating and one has assigned a Hold rating to the company's stock. According to MarketBeat, HealthEquity currently has an average rating of "Buy" and a consensus target price of $118.55.

Check Out Our Latest Analysis on HealthEquity

HealthEquity Profile

(Free Report)

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.

Recommended Stories

Institutional Ownership by Quarter for HealthEquity (NASDAQ:HQY)

Should You Invest $1,000 in HealthEquity Right Now?

Before you consider HealthEquity, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HealthEquity wasn't on the list.

While HealthEquity currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

NVIDIA Earnings: All Signs Point to More Growth Ahead
3 Quiet Growth Stocks With Major Momentum
The Market’s Next Big Winners? Start Here

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines